Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

Published:2022-12-26 Issue:4 Volume:58 Page:452-455
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kimura Shun-ichi^ORCID,Shimizu Hiroaki,Miyazaki Takuya,Sakurai Masatoshi^ORCID,Tanoue Susumu,Kayamori Kensuke^ORCID,Ohwada Chikako^ORCID,Yoshimura Kazuki^ORCID,Nakasone Hideki^ORCID,Ohashi Takuma^ORCID,Shono Katsuhiro^ORCID,Tachibana Takayoshi^ORCID,Hatano Kaoru,Okada Keigo,Kimura Yuta,Seo Sachiko,Doki Noriko,Tanaka Masatsugu,Hatta Yoshihiro,Takahashi Satoshi^ORCID,Kanda Yoshinobu^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01901-5.pdf

Reference12 articles.

1. Farag SS, Abu Zaid M, Schwartz JE, Thakrar TC, Blakley AJ, Abonour R, et al. Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease. N Engl J Med. 2021;384:11–9.

2. Hatano R, Ohnuma K, Yamamoto J, Dang NH, Morimoto C. CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production. Immunology. 2013;138:165–72.

3. Shulman HM, Sale GE, Lerner KG, Barker EA, Weiden PL, Sullivan K, et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol. 1978;91:545–70.

4. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267–76.

5. Farag SS, Nelson R, Cairo MS, O’Leary HA, Zhang S, Huntley C, et al. High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation. Oncotarget. 2017;8:110350–7.